Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology
Nidheesh ThadathilMohammad Moshahid Khan

Abstract

Parkinson's disease (PD) is characterized by progressive degeneration of dopaminergic neurons in the substantia nigra and loss of both motor and non-motor features. Several clinical and preclinical studies have provided evidence that estrogen therapy reduces the risk of PD but have limitations in terms of adverse peripheral effects. Therefore, we examined the potential beneficial effects of the brain-selective estrogen prodrug, 10β, 17β-dihydroxyestra-1,4-dien-3-one (DHED) on nigrostriatal dopaminergic neurodegeneration and behavioral abnormalities in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. Wild-type mice were treated with daily subcutaneous injections of DHED (50 and 100 µg/kg) or vehicle for four weeks. To produce PD-like symptoms, mice were injected with MPTP (18 mg/kg in saline; intraperitoneally) four times at 2-hr intervals for one day. After behavioral examination, mice were sacrificed, and the brains were isolated for neurochemical and morphological examinations. MPTP injected mice exhibited loss of dopaminergic neurons and fibers in substantia nigra and striatum respectively, along with impaired motor function at day 7 post MPTP injection. These phenotypes were associated with significant...Continue Reading

References

Sep 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·V Jackson-LewisS Przedborski
Dec 8, 1998·Journal of Neuroscience Research·H SawadaS Shimohama
Jul 6, 2000·Progress in Neurobiology·R Dringen
Jul 4, 2001·Nature Reviews. Neuroscience·M Goedert
Jun 5, 2003·American Journal of Epidemiology·Stephen K Van Den EedenLorene M Nelson
Jul 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Elisabetta VegetoAdriana Maggi
Sep 16, 2003·Neuron·William Dauer, Serge Przedborski
May 5, 2005·Experimental Neurology·Andreas Hald, Julie Lotharius
May 24, 2006·Neurology·Peter Jenner, C Warren Olanow
Oct 10, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Paolo RagoneseGiovanni Savettieri
Dec 7, 2007·Clinical Neuroscience Research·R Lee MosleyHoward E Gendelman
Jan 30, 2010·Parkinsonism & Related Disorders·Yasuomi OuchiMasanobu Sakamoto
Feb 5, 2010·Leukemia·L-J MahT C Karagiannis
May 27, 2010·Cellular and Molecular Life Sciences : CMLS·Antoni CaminsMercè Pallàs
Apr 9, 2011·Antioxidants & Redox Signaling·Tohru Fukai, Masuko Ushio-Fukai
Oct 26, 2011·Biochimica Et Biophysica Acta·Leonid BreydoVladimir N Uversky
Jan 19, 2013·Free Radical Biology & Medicine·Laurie H Sanders, J Timothy Greenamyre
Feb 9, 2013·Neurochemistry International·Mohammad Moshahid KhanAsgar Zaheer
Jun 19, 2013·Neurobiology of Disease·Ana I Rodriguez-PerezJose L Labandeira-Garcia
Nov 21, 2013·Journal of Parkinson's Disease·Vera DiasM Maral Mouradian
Sep 11, 2014·Frontiers in Pharmacology·Katia AquilanoMaria R Ciriolo
Jul 24, 2015·Science Translational Medicine·Laszlo ProkaiKatalin Prokai-Tatrai
Nov 26, 2015·Mutation Research. Reviews in Mutation Research·Mohammad Sabbir SiddiquiWayne R Leifert
Apr 23, 2016·Neuroepidemiology·Lauren HirschTamara Pringsheim
Apr 25, 2016·Progress in Neurobiology·Valerie JoersAnna R Carta
Nov 8, 2016·Biochemical and Biophysical Research Communications·Degui WangYingxia Tian
Nov 16, 2016·Oxidative Medicine and Cellular Longevity·Roshni ThakkarDarrell Brann
Feb 19, 2017·Biochemical and Biophysical Research Communications·Michael M Gaschler, Brent R Stockwell
Nov 21, 2017·Neurobiology of Aging·Mohammad Moshahid KhanMark S LeDoux
Jul 28, 2018·Cell Death & Disease·Chiara MilanesePier G Mastroberardino
Aug 14, 2019·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Molly M RajsombathSilke Nuber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.